Immunome (IMNM) Operating Leases (2023 - 2026)

Immunome's (IMNM) quarterly Operating Leases came in at $3.7 million in Q1 2026, down 22.56% YoY from $4.8 million in Q1 2025, and down 4.18% on a QoQ basis from $3.9 million in Q4 2025.

Immunome (IMNM) Operating Leases (2023 - 2026) Analysis & Trends

Immunome (IMNM) has 4 years of Operating Leases data on file, last reported at $3.7 million in Q1 2026.

  • Quarterly Operating Leases fell 22.56% year-over-year to $3.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.7 million (down 22.56% YoY) and the FY2025 annual result came in at $3.9 million, down 19.17% from the prior year.
  • Operating Leases fell to $3.7 million in Q1 2026, from $3.9 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $4.8 million in Q1 2025 to a low of $1.2 million in Q1 2024.
  • A 4-year average of $3.1 million and a median of $3.7 million in 2026 frame the typical range for Operating Leases.
  • Annual changes were most pronounced in 2025 — Operating Leases surged 295.52% — and 2026, when it slipped 22.56%.
  • Tracing IMNM's Operating Leases over 4 years: stood at $1.3 million in 2023, then jumped by 255.9% to $4.8 million in 2024, then retreated by 19.17% to $3.9 million in 2025, then retreated by 4.18% to $3.7 million in 2026.
  • The last three Operating Leases figures came in at $3.7 million (Q1 2026), $3.9 million (Q4 2025), and $4.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Immunome 3.09 Bn 2.57 Bn -

Historic Data

Download Data
DateValue
Jun 30, 2026 4.59 Mn
Mar 31, 2026 3.69 Mn
Dec 31, 2025 3.86 Mn
Sep 30, 2025 4.01 Mn
Jun 30, 2025 4.14 Mn
Mar 31, 2025 4.77 Mn
Dec 31, 2024 4.77 Mn
Sep 30, 2024 2.46 Mn
Jun 30, 2024 2.48 Mn
Mar 31, 2024 1.21 Mn
Dec 31, 2023 1.34 Mn
Mar 31, 2023 1.34 Mn